14 / 24
14 ARCHBOLD
MEDICAL CENTER
CLINICAL TRIALS
Leading the region in
oncology clinical research
Archbold is actively accepting patients for 9 of 17 clinical trials/
registries the hospital is currently involved in, a remarkable number
for a hospital outside a metropolitan area. And as the sophisticated
program continues to grow, it’s the patients that benefit. Clinical trials
Archbold patients and physicians are involved with have the potential
to help thousands of patients worldwide.
Lung cancer (two trials)
Eligible participants
include patients with
Stage IV lung cancer
who have never had
chemotherapy treat-
ment, as well as patients
with completely
resected non-small-cell
lung cancer and good
performance status.
Lymphoma
Eligible participants
may include patients
with untreated
CD20-positive
follicular lymphoma
and patients with
no symptoms of
lymphoma.
The Singletary Oncology Center oncology research team (from left): Tiffany
Woolum, RN; Lenore Beckett, RN; Josh Simmons, MD; Teresa Coleman,MD,
FACP; and Lisa Speigner, RN.
of cancer care, right here